ArticleBiomedicines2025

Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer.

Fernando Lago-Ballester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.